Team

bernat-olle-ph-d

Bernat Olle, Ph.D.

Chief Executive Officer

bernat-olle-ph-d

Bernat Olle, Ph.D.

Chief Executive Officer

Dr. Olle is a co-founder and Chief Executive Officer of Vedanta Biosciences. He has been a member of the founding teams of several companies of the PureTech portfolio and served as a member of the Board of Directors of Vedanta Biosciences and Follica Biosciences.

In 2013 Dr. Olle was named "Innovator of the Year" in MIT Technology Review Spain's "Innovators under 35" awards. He completed his doctoral work at the Chemical Engineering Department at MIT, where he developed a novel method for large-scale bacterial culture. During his graduate work, Dr. Olle was awarded the "la Caixa" fellowship. Dr. Olle received his B.S. in Chemical Engineering from Universitat Rovira i Virgili, in the Republic of Catalonia, his M.S. and PhD. in Chemical Engineering Practice from MIT, and his M.B.A. from the MIT Sloan School of Management. He has published his work in journals including Nature and Nature Biotechnology.

Ending the War on Microbes | Bernat Olle | TEDxCambridge

bruce-roberts-ph-d

Bruce Roberts, Ph.D.

Chief Scientific Officer

bruce-roberts-ph-d

Bruce Roberts, Ph.D.

Chief Scientific Officer

Dr. Roberts has 30 years of experience in biotechnology and pharmaceutical drug discovery and development. He most recently served as Head of Neuro-Immunology and Immune-Mediated Disease Research at Sanofi Genzyme where he directed pre-clinical efforts resulting in the introduction of therapeutic antibodies, gene therapies, cell therapies and small molecules into multiple clinical trials for the treatment of cancer, multiple sclerosis and autoimmunity. He also directed research efforts in support of several approved products including lemtrada, aubagio, thymoglobulin, Mozobil, alemtuzumab, leukine, chlofarabine and fludarabine and contributed to the generation of ecallantide.

Dr. Roberts has authored more than 50 peer-reviewed publications and contributed to several issued patents and patent applications. He received his PhD. in Biochemistry from the University of Ottawa, Canada.

jonathan-freeman-ph-d

Jonathan Freeman, Ph.D.

Chief Business Officer

jonathan-freeman-ph-d

Jonathan Freeman, Ph.D.

Chief Business Officer

Jonathan Freeman is Vedanta's Chief Business Officer. An industry veteran, Jonathan joined Vedanta following a career spanning two decades in leading roles within Merck KGaA, Baxter and Serono. Within Merck, Jonathan served as Senior Vice President, Head of Strategy Development and Portfolio Management, overseeing asset valuation, capital allocation, and strategy development guiding investment and corporate shifts resulting in, amongst other things, the launch of Bavencio in collaboration with Pfizer. Prior to Merck, Jonathan was Director of European M&A for Baxter, where he defined and executed external growth strategy, established commercial and manufacturing joint ventures, constructed, financed, and executed strategic business models and alliances working alongside multinational investment groups such as TPG and Goldman Sachs. During his time with Serono, Jonathan was Director of Corporate and Business Development, leading licensing, alliance management, the management of private equity relationships, and participating broadly in Corporate M&A. Jonathan was a former Vice President of the Swiss Pharma Licensing Group (now SwissHLG), representative to the International Pharma Society, a faculty member of the European Centre for Pharmaceutical Medicine (ECPM), and an Editor of the Business Development & Licensing Journal. Jonathan holds a First Class Honours BA in Biochemistry and an MA from Cambridge University, a Ph.D. in Molecular Pharmacology from the Imperial Cancer Research Fund (now CRUK) at the Edinburgh University Medical School, and an MBA from Geneva and Webster, St Louis Universities. Prior to entering the industry, Jonathan held assistant professor and post-doctoral positions in cancer research, gene therapy and virology in several leading academic settings including the Swiss Institute for Cancer Research (ISREC) and the Geneva Medical School (CMU) obtaining funding from the European Molecular Biology Laboratory (EMBL) and the Royal Society of London.

lou-vaickus-m-d-facp

Lou Vaickus, M.D. FACP

Interim Chief Medical Officer

lou-vaickus-m-d-facp

Lou Vaickus, M.D. FACP

Interim Chief Medical Officer

Lou Vaickus, M.D. FACP, serves as Interim Chief Medical Officer of Vedanta. Dr. Vaickus is Chief Executive Officer and Founder of akta Pharmaceutical Development LLC (aktaPD®). Dr. Vaickus has served as Interim Chief Medical Officer at several biotech companies, most recently at Verastem, Inc. and InVivo Therapeutics Holdings Corp. Dr. Vaickus’ therapeutic areas of specialization include development of NCEs, biologics, biosimilars, and live biotherapeutic products in oncology, hematology, pulmonary and other fibrotic disorders, infectious diseases, autoimmunity, rare metabolic disorders, immunology and medical devices. He has over 30 years of experience that began as an academic scientist and practicing physician, then spanned into industry with preclinical, clinical, and globally marketed pharmaceutical products. In industry, Lou served as Vice President and Head of Clinical Development, Global Medicines Development and Affairs at Vertex Pharmaceuticals. Before joining Vertex, Dr. Vaickus was Chief Medical Officer of Tolerx, Inc. from 2002 to 2011. Previously, he served as Vice President of Clinical Research and later as Senior Vice President of Medical Affairs at Sunovion (formerly Sepracor, Inc.), Medical Director of Oncology/Immunology at EMD Serono (formerly Ares Serono), where he supervised clinical and medical affairs for Rebif®, and Associate Medical Director, Medical Director, and later Medical Marketing Director for the Rebif® Multiple Sclerosis Strategic Business Unit at Serono. Dr. Vaickus is board certified in Internal Medicine, Hematology, and Medical Oncology. He completed postdoctoral fellowships in hematology, oncology, and immunology at the Mayo Clinic and Stanford University. Dr. Vaickus has held faculty positions at the U of Iowa (Division of Hematology/Oncology) and at Roswell Park Cancer Institute/SUNY Buffalo (Divisions of Clinical Immunology, Bone Marrow Transplant, Hematologic Malignancies, and Solid Tumor Oncology and Investigational Therapeutics). Dr. Vaickus holds an M.D. from Loyola University's Stritch School of Medicine.

dan-couto

Dan Couto

Chief Technology Officer

dan-couto

Dan Couto

Chief Technology Officer

Mr. Couto has 25 years of experience in biotechnology, biologics drug development and cGMP manufacturing, including at Merck Sharp Dohme Biologics UK (formerly Avecia Biologics) where he served as Vice President of Commercial Manufacturing Operations and was responsible for late stage and commercial manufacturing operations. In addition, Mr. Couto has held senior positions with several biotech companies including Nuvelo, Genzyme Transgenics and Advanced Biosystems and, most recently, was Senior Vice President of Manufacturing and Facilities Operations at ContraFect Corporation where he was responsible for chemistry & manufacturing controls, supply chain, quality assurance and facilities.

Mr. Couto holds multiple U.S. patents. He received his B.S. in Chemical Engineering from Rensselaer Polytechnic Institute.

erik-spek-ph-d-j-d

Erik Spek, Ph.D., J.D.

Vice President - Head of Intellectual Property

erik-spek-ph-d-j-d

Erik Spek, Ph.D., J.D.

Vice President - Head of Intellectual Property

Erik Spek is the head of Intellectual Property at Vedanta. Prior to his current position, Erik was Director of IP at Epizyme and worked at Boston-based IP law firm Wolf Greenfield. Erik graduated cum laude from Suffolk Law School in Boston. He earned his B.S. in Chemistry and Philosophy from Vrije Universiteit in Amsterdam and his PhD. in Biophysical Chemistry from New York University.

debra-winslow

Debra Winslow

VP Program Management & Operations Planning

debra-winslow

Debra Winslow

VP Program Management & Operations Planning

Deb Winslow has joined Vedanta after working in the biotech industry for over 25 years in various roles from early product development through commercialization.  She received a BS in biochemistry from UNH, an MBA from Bentley University, is a Regulatory Affairs Certified (RAC) professional and a Project Management Professional (PMP).  Her roles is to set up program management and operational planning systems to ensure successful program execution across the company.

lauren-cataldo

Lauren Cataldo

Operations Manager

sharon-stanford

Sharon Stanford

Office Coordinator

tom-parrotta

Tom Parrotta

Manager of Grants Administration and Accounts Payable

james-honohan

James Honohan

Accounts Payable

jeff-kagy

Jeff Kagy

Talent Acquisition Specialist

brian-klein-ph-d

Brian Klein, Ph.D.

Staff Scientist I

james-llewellyn

James Llewellyn

Senior Research Associate

colin-lazzara

Colin Lazzara

Research Associate

jason-norman-ph-d

Jason Norman, Ph.D.

Senior Scientist

adam-krebs

Adam Krebs

Senior Research Associate

colin-heberling

Colin Heberling

Senior Research Associate Bioinformatics

gouri-vadali

Gouri Vadali

Research Associate/Bioinformatics

silvia-caballero-ph-d

Silvia Caballero, Ph.D.

Scientist II

cintia-felix

Cintia Felix

Senior Research Associate

krishnaveni-ramanan

Krishnaveni Ramanan

Senior Research Associate

allison-shottek

Allison Shottek

Research Assistant

rose-szabady-ph-d

Rose Szabady, Ph.D.

Senior Staff Scientist

michael-mosho

Michael Mosho

Research Associate

amanda-costa

Amanda Costa

Research Associate/Immunology

shilpa-reddy

Shilpa Reddy

Principal Research Associate

cherylyn-smith

Cherylyn Smith

Lab Manager

amy-pepicelli

Amy Pepicelli

Research Associate

ryan-busha

Ryan Busha

Senior Clinical Research Manager

maria-kim

Maria Kim

Clinical Trial Associate

kris-ireland

Kris Ireland

Director of Manufacturing

robert-drsquo-orazio

Robert D’Orazio

Senior Manufacturing Associate

steve-derby

Steve Derby

Manufacturing Associate

alicia-szretter

Alicia Szretter

Manufacturing Supervisor

mike-maynard

Mike Maynard

Manufacturing Associate

andrew-croteau

Andrew Croteau

Quality Consultant

scott-michonski

Scott Michonski

Manager of Process Development & Technical Operations, Upstream

jil-ulrich

Jil Ulrich

Manager of Process Development & Technical Operations, Downstream

ketaki-nade

Ketaki Nade

Analytical Development

brian-howe

Brian Howe

Facility Manager

deb-rich

Deb Rich

Senior Quality Consultant - Warren Cove Consulting, LLC

evan-kustubardis

Evan Kustubardis

Quality Consultant - Azzur Group, LLC

dave-crane

Dave Crane

Quality Consultant - Azzur Group, LLC

alex-buckley

Alex Buckley

Quality Consultant - Azzur Group, LLC

melissa-smith

Melissa Smith

Quality Consultant